Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.

Key Points

• The research aims to assess the effectiveness of drug-coated balloon (DCB) treatment versus drug-eluting stent (DES) only in patients with high-bleeding risk (HBR).
• Compared outcomes of DCB-based percutaneous coronary intervention (PCI) and DES-only treatments.
• Analyzed major adverse cardiovascular events (MACE) among patients with HBR.
• DCB-based PCI was associated with a significantly lower risk of MACE compared to DES-only treatment.
• Improving outcomes for patients with high-bleeding risk was suggested as a key advantage of DCB.